These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

996 related articles for article (PubMed ID: 20007413)

  • 1. Neuropsychological consequences of alcohol and drug abuse on different components of executive functions.
    Fernández-Serrano MJ; Pérez-García M; Schmidt Río-Valle J; Verdejo-García A
    J Psychopharmacol; 2010 Sep; 24(9):1317-32. PubMed ID: 20007413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of executive dysfunction in cocaine, heroin and alcohol users enrolled in therapeutic communities.
    Fernández-Serrano MJ; Pérez-García M; Perales JC; Verdejo-García A
    Eur J Pharmacol; 2010 Jan; 626(1):104-12. PubMed ID: 19836375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis.
    Verdejo-García AJ; López-Torrecillas F; Aguilar de Arcos F; Pérez-García M
    Addict Behav; 2005 Jan; 30(1):89-101. PubMed ID: 15561451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profile of executive deficits in cocaine and heroin polysubstance users: common and differential effects on separate executive components.
    Verdejo-García A; Pérez-García M
    Psychopharmacology (Berl); 2007 Mar; 190(4):517-30. PubMed ID: 17136401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of severity of drug use on discrete emotions recognition in polysubstance abusers.
    Fernández-Serrano MJ; Lozano O; Pérez-García M; Verdejo-García A
    Drug Alcohol Depend; 2010 Jun; 109(1-3):57-64. PubMed ID: 20064697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impulsivity in cocaine and heroin polysubstance abusers.
    Verdejo-García AJ; Perales JC; Pérez-García M
    Addict Behav; 2007 May; 32(5):950-66. PubMed ID: 16876962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The frontal assessment battery (FAB) reveals neurocognitive dysfunction in substance-dependent individuals in distinct executive domains: Abstract reasoning, motor programming, and cognitive flexibility.
    Cunha PJ; Nicastri S; de Andrade AG; Bolla KI
    Addict Behav; 2010 Oct; 35(10):875-81. PubMed ID: 20584570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The impact exerted by the severity of recreational drug abuse on the different components of the executive function].
    Verdejo A; Orozco-Giménez C; Meersmans Sánchez-Jofré M; Aguilar de Arcos F; Pérez-García M
    Rev Neurol; 2004 Jun 16-30; 38(12):1109-16. PubMed ID: 15229821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers.
    Verdejo A; Toribio I; Orozco C; Puente KL; Pérez-García M
    Drug Alcohol Depend; 2005 Jun; 78(3):283-8. PubMed ID: 15893159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What are the specific vs. generalized effects of drugs of abuse on neuropsychological performance?
    Fernández-Serrano MJ; Pérez-García M; Verdejo-García A
    Neurosci Biobehav Rev; 2011 Jan; 35(3):377-406. PubMed ID: 20451551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions.
    Lundqvist T
    Pharmacol Biochem Behav; 2005 Jun; 81(2):319-30. PubMed ID: 15925403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-related decrease in neuropsychological functions of abstinent drug users.
    van Holst RJ; Schilt T
    Curr Drug Abuse Rev; 2011 Mar; 4(1):42-56. PubMed ID: 21466500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is moderate substance use associated with altered executive functioning in a population-based sample of young adults?
    Piechatzek M; Indlekofer F; Daamen M; Glasmacher C; Lieb R; Pfister H; Tucha O; Lange KW; Wittchen HU; Schütz CG
    Hum Psychopharmacol; 2009 Dec; 24(8):650-65. PubMed ID: 19946940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Goal Management Training and Mindfulness meditation improve executive functions and decision-making performance in abstinent polysubstance abusers.
    Alfonso JP; Caracuel A; Delgado-Pastor LC; Verdejo-García A
    Drug Alcohol Depend; 2011 Aug; 117(1):78-81. PubMed ID: 21277705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impulsivity and executive functions in polysubstance-using rave attenders.
    Verdejo-García A; Del Mar Sánchez-Fernández M; Alonso-Maroto LM; Fernández-Calderón F; Perales JC; Lozano O; Pérez-García M
    Psychopharmacology (Berl); 2010 Jun; 210(3):377-92. PubMed ID: 20386885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuroimaging and drug addiction: neuroanatomical correlates of cocaine, opiates, cannabis and ecstasy abuse].
    Verdejo-García A; Pérez-García M; Sánchez-Barrera M; Rodriguez-Fernández A; Gómez-Río M
    Rev Neurol; 2007 Apr 1-15; 44(7):432-9. PubMed ID: 17420970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
    Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
    Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.